1. Home
  2. SHMD vs QNCX Comparison

SHMD vs QNCX Comparison

Compare SHMD & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SCHMID Group N.V. Class A Ordinary Shares

SHMD

SCHMID Group N.V. Class A Ordinary Shares

HOLD

Current Price

$5.93

Market Cap

323.0M

Sector

N/A

ML Signal

HOLD

Logo Quince Therapeutics Inc.

QNCX

Quince Therapeutics Inc.

HOLD

Current Price

$0.09

Market Cap

167.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SHMD
QNCX
Founded
1864
2012
Country
Germany
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
323.0M
167.0M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
SHMD
QNCX
Price
$5.93
$0.09
Analyst Decision
Hold
Analyst Count
0
3
Target Price
N/A
$10.00
AVG Volume (30 Days)
828.9K
15.5M
Earning Date
05-15-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.00
$0.08
52 Week High
$10.65
$4.55

Technical Indicators

Market Signals
Indicator
SHMD
QNCX
Relative Strength Index (RSI) 42.37 28.62
Support Level $5.75 N/A
Resistance Level $6.70 $0.98
Average True Range (ATR) 0.71 0.01
MACD 0.02 0.05
Stochastic Oscillator 5.95 18.58

Price Performance

Historical Comparison
SHMD
QNCX

About SHMD SCHMID Group N.V. Class A Ordinary Shares

Schmid Group NV is a global supplier of equipment, software and services for various industries such as printed circuit board (PCB), substrate manufacturing, photovoltaics, and glass and energy storage with a focus on the highest end of this market in terms of technology and performance. It focuses on a modular product portfolio of machinery to use in the manufacturing of high-end PCB equipment and semiconductor packaging devices which includes common flexible circuit fabrication techniques such as subtractive, semi-additive processes (SAP) and modified semi-additive processes (mSAP).

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.

Share on Social Networks: